HPC Biosciences financials at a glance
| Year | Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
47.70M | 35.26M | 32.64M | 20.10M | 24.44M | 20.83M | 16.90M | 12.00M | 22.86M | 4.90M | 2.11M | 0.00M |
| GM % | Gross Margin % |
|
100.49% | 86.73% | 87.83% | 129.19% | 98.48% | 85.26% | 97.68% | 93.51% | 88.83% | -11.90% | 100.00% | 0.00% |
| OM | Operating Margin |
|
66.11% | 38.89% | 23.19% | 25.49% | 23.13% | 11.48% | 34.16% | 21.43% | 48.39% | -183.27% | -247.92% | 0.00% |
| EPS | Earnings Per Share |
|
0.00 | |||||||||||
| Div. | Dividends |
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
0m | 159.6m | 159.6m | 159.6m | 159.6m | 159.6m | 159.6m | 159.6m | 0m | 159.6m | 159.6m | 159.6m |
| OCF | Operating Cash Flow |
|
33.97M | 39.95M | 2.21M | -1.84M | 10.92M | 0.80M | 11.74M | 8.23M | 13.60M | 0.85M | -3.48M | 0.00M |
| FCF | Free Cash Flow |
|
-73.99M | 36.70M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| FCFS | Free Cash Flow Per Share |
|
-0.86 | 0.23 | 0.01 | -0.01 | 0.07 | 0.01 | 0.07 | 0.05 | 0.09 | 0.00 | 0.00 | 0.00 |